BamSEC and AlphaSense Join Forces
Learn More

TNF Pharmaceuticals Inc.

NASDAQ: TNFA    
Share price (12/20/24): $1.36    
Market cap (12/20/24): $3.747 million

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Designations of Series G Convertible Preferred Stock of TNF Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Tnf Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of MyMD Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Designations of Series G Convertible Preferred Stock of MyMD Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Designations of Series G Convertible Preferred Stock of MyMD Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 8-K 54 pages Certificate of Designations of Series F-1 Convertible Preferred Stock of MyMD Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 47 pages Certificate of Designations of Series G Convertible Preferred Stock of MyMD Pharmaceuticals, Inc
12/34/56
EX-3.3
from 8-K 4 pages Certificate of Amendment of Amended and Restated Certificate of Designations of Series F Convertible Preferred Stock of MyMD Pharmaceuticals, Inc. Pursuant to Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 8-K 57 pages Certificate of Designations of Series F-1 Convertible Preferred Stock of MyMD Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 47 pages Certificate of Designations of Series G Convertible Preferred Stock of MyMD Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 60 pages Terms of Preferred Stock
12/34/56
EX-3.3
from 8-K/A 1 page Certificate of Correction of MyMD Pharmaceuticals, Inc., a Delaware Corporation
12/34/56
EX-3.2
from 8-K 30 pages Bylaws of MyMD Pharmaceuticals, Inc. a Delaware Corporation
12/34/56
EX-3.1
from 8-K 77 pages Certificate of Incorporation of MyMD Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages New Jersey Division of Revenue Certificate of Amendment to the Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 43 pages Certificate of Designations of Series F Convertible Preferred Stock of MyMD Pharmaceuticals, Inc
12/34/56
EX-3.3
from 8-K 12 pages Amended and Restated Bylaws of MYMD Pharmaceuticals, Inc. a New Jersey Corporation
12/34/56
EX-3.2
from 8-K 3 pages New Jersey Division of Revenue Certificate of Amendment to the Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 36 pages Certificate Required to Be Filed With the Restated Certificate of Incorporation
12/34/56
EX-3.13
from 10-K/A 2 pages Articles of Incorporation or Bylaws
12/34/56